329 related articles for article (PubMed ID: 29293660)
21. Determining the breadth of the respiratory syncytial virus-specific T cell response.
McDermott DS; Knudson CJ; Varga SM
J Virol; 2014 Mar; 88(6):3135-43. PubMed ID: 24371055
[TBL] [Abstract][Full Text] [Related]
22. Resistance to respiratory syncytial virus (RSV) challenge induced by infection with a vaccinia virus recombinant expressing the RSV M2 protein (Vac-M2) is mediated by CD8+ T cells, while that induced by Vac-F or Vac-G recombinants is mediated by antibodies.
Connors M; Kulkarni AB; Collins PL; Firestone CY; Holmes KL; Morse HC; Murphy BR
J Virol; 1992 Feb; 66(2):1277-81. PubMed ID: 1731105
[TBL] [Abstract][Full Text] [Related]
23. Pulmonary T cells induced by respiratory syncytial virus are functional and can make an important contribution to long-lived protective immunity.
Ostler T; Ehl S
Eur J Immunol; 2002 Sep; 32(9):2562-9. PubMed ID: 12207340
[TBL] [Abstract][Full Text] [Related]
24. Effect of Previous Respiratory Syncytial Virus Infection on Murine Immune Responses to F and G Protein-Containing Virus-Like Particles.
McGinnes Cullen L; Schmidt MR; Morrison TG
J Virol; 2019 May; 93(9):. PubMed ID: 30760576
[TBL] [Abstract][Full Text] [Related]
25. Recombinant baculovirus-based vaccine expressing M2 protein induces protective CD8
Lee JY; Chang J
J Microbiol; 2017 Nov; 55(11):900-908. PubMed ID: 29076066
[TBL] [Abstract][Full Text] [Related]
26. Alum Adjuvant Enhances Protection against Respiratory Syncytial Virus but Exacerbates Pulmonary Inflammation by Modulating Multiple Innate and Adaptive Immune Cells.
Kim KH; Lee YT; Hwang HS; Kwon YM; Jung YJ; Lee Y; Lee JS; Lee YN; Park S; Kang SM
PLoS One; 2015; 10(10):e0139916. PubMed ID: 26468884
[TBL] [Abstract][Full Text] [Related]
27. Enhanced humoral and CD8+ T cell immunity in mice vaccinated by DNA vaccine against human respiratory syncytial virus through targeting the encoded F protein to dendritic cells.
Hua Y; Jiao YY; Ma Y; Peng XL; Fu YH; Zhang XJ; Zheng YB; Zheng YP; Hong T; He JS
Int Immunopharmacol; 2017 May; 46():62-69. PubMed ID: 28259002
[TBL] [Abstract][Full Text] [Related]
28. Infection of mice with respiratory syncytial virus during neonatal life primes for enhanced antibody and T cell responses on secondary challenge.
Tasker L; Lindsay RW; Clarke BT; Cochrane DW; Hou S
Clin Exp Immunol; 2008 Aug; 153(2):277-88. PubMed ID: 18549446
[TBL] [Abstract][Full Text] [Related]
29. DNGR-1 is dispensable for CD8+ T-cell priming during respiratory syncytial virus infection.
Durant LR; Pereira C; Boakye A; Makris S; Kausar F; Goritzka M; Johansson C
Eur J Immunol; 2014 Aug; 44(8):2340-8. PubMed ID: 24777856
[TBL] [Abstract][Full Text] [Related]
30. Interleukin 18 coexpression during respiratory syncytial virus infection results in enhanced disease mediated by natural killer cells.
Harker JA; Godlee A; Wahlsten JL; Lee DC; Thorne LG; Sawant D; Tregoning JS; Caspi RR; Bukreyev A; Collins PL; Openshaw PJ
J Virol; 2010 Apr; 84(8):4073-82. PubMed ID: 20130064
[TBL] [Abstract][Full Text] [Related]
31. Virus-specific memory and effector T lymphocytes exhibit different cytokine responses to antigens during experimental murine respiratory syncytial virus infection.
Srikiatkhachorn A; Braciale TJ
J Virol; 1997 Jan; 71(1):678-85. PubMed ID: 8985399
[TBL] [Abstract][Full Text] [Related]
32. Multiple CD4+ T cell subsets produce immunomodulatory IL-10 during respiratory syncytial virus infection.
Weiss KA; Christiaansen AF; Fulton RB; Meyerholz DK; Varga SM
J Immunol; 2011 Sep; 187(6):3145-54. PubMed ID: 21844390
[TBL] [Abstract][Full Text] [Related]
33. Serum antibodies critically affect virus-specific CD4+/CD8+ T cell balance during respiratory syncytial virus infections.
Kruijsen D; Bakkers MJ; van Uden NO; Viveen MC; van der Sluis TC; Kimpen JL; Leusen JH; Coenjaerts FE; van Bleek GM
J Immunol; 2010 Dec; 185(11):6489-98. PubMed ID: 20971927
[TBL] [Abstract][Full Text] [Related]
34. Cytokines and CD8 T cell immunity during respiratory syncytial virus infection.
Schmidt ME; Varga SM
Cytokine; 2020 Sep; 133():154481. PubMed ID: 30031680
[TBL] [Abstract][Full Text] [Related]
35. Type I interferons and MAVS signaling are necessary for tissue resident memory CD8+ T cell responses to RSV infection.
Varese A; Nakawesi J; Farias A; Kirsebom FCM; Paulsen M; Nuriev R; Johansson C
PLoS Pathog; 2022 Feb; 18(2):e1010272. PubMed ID: 35108347
[TBL] [Abstract][Full Text] [Related]
36. Vaccination with a Single-Cycle Respiratory Syncytial Virus Is Immunogenic and Protective in Mice.
Schmidt ME; Oomens AGP; Varga SM
J Immunol; 2019 Jun; 202(11):3234-3245. PubMed ID: 31004010
[TBL] [Abstract][Full Text] [Related]
37. Long-term persistence and reactivation of T cell memory in the lung of mice infected with respiratory syncytial virus.
Ostler T; Hussell T; Surh CD; Openshaw P; Ehl S
Eur J Immunol; 2001 Sep; 31(9):2574-82. PubMed ID: 11536155
[TBL] [Abstract][Full Text] [Related]
38. Non-propagating, recombinant vesicular stomatitis virus vectors encoding respiratory syncytial virus proteins generate potent humoral and cellular immunity against RSV and are protective in mice.
Johnson JE; McNeil LK; Megati S; Witko SE; Roopchand VS; Obregon JH; Illenberger DM; Kotash CS; Nowak RM; Braunstein E; Yurgelonis I; Jansen KU; Kalyan NK; Sidhu MK
Immunol Lett; 2013 Feb; 150(1-2):134-44. PubMed ID: 23261719
[TBL] [Abstract][Full Text] [Related]
39. Depletion of regulatory T-cells leads to moderate B-cell antigenicity in respiratory syncytial virus infection.
Shao HY; Huang JY; Lin YW; Yu SL; Chitra E; Chang CK; Sung WC; Chong P; Chow YH
Int J Infect Dis; 2015 Dec; 41():56-64. PubMed ID: 26555647
[TBL] [Abstract][Full Text] [Related]
40. Interleukin-4 diminishes CD8(+) respiratory syncytial virus-specific cytotoxic T-lymphocyte activity in vivo.
Aung S; Tang YW; Graham BS
J Virol; 1999 Nov; 73(11):8944-9. PubMed ID: 10515999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
